Irregular heartbeats can signal AFib. Early detection and appropriate treatments help manage it and protect long-term heart health.
Jaypirca is approved for the treatment of adults with relapsed or refractory CLL/SLL who were previously treated with a ...
StyleBlueprint on MSN
Are Your Flossing Habits Affecting Your Heart Health?
Studies show clear links between dental health and heart disease. Brush up on ideal oral hygiene habits (and the surprising ...
Noncovalent Bruton tyrosine kinase inhibitors like pirtobrutinib may be a more effective first-line therapy for chronic ...
Clinical Trials Arena on MSN
Eli Lilly reports Phase III trial results of Jaypirca for CLL/SLL
The results demonstrated that pirtobrutinib met its primary endpoint of non-inferiority on ORR against ibrutinib.
Pirtobrutinib, a non-covalent Bruton tyrosine kinase (BTK) inhibitor, met the primary endpoint for non-inferiority in terms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results